Cytosorbents
CTSO
#10612
Rank
S$29.08 M
Marketcap
S$0.46
Share price
3.08%
Change (1 day)
-60.52%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2026 (TTM): -S$15.78 Million

According to Cytosorbents's latest financial reports the company's current earnings are S$37.2 Million. In 2025 the company made an earning of -S$11.03 Million, an increase over its 2024 earnings that were of -S$29.15 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$15.78 Million43.05%
2025 -S$11.03 Million-62.16%
2024 -S$29.15 Million-22.49%
2023 -S$37.61 Million-13.52%
2022 -S$43.49 Million34.04%
2021 -S$32.45 Million182.17%
2020 -S$11.5 Million-55.97%
2019 -S$26.12 Million14.17%
2018 -S$22.87 Million95.14%
2017 -S$11.72 Million-22.32%
2016 -S$15.09 Million39.1%
2015 -S$10.85 Million-12.89%
2014 -S$12.46 Million89%
2013 -S$6.59 Million26.65%
2012 -S$5.21 Million-26.02%
2011 -S$7.04 Million-288.45%
2010 S$3.73 M-4.17%
2009 S$3.89 M-287.19%
2008 -S$2.08 Million-47.12%
2007 -S$3.94 Million41.78%
2006 -S$2.78 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
S$4.79 B-30,646.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
S$0.99 B-6,447.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO
S$71.18 M-553.11%๐Ÿ‡บ๐Ÿ‡ธ USA